Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis

In conclusion, S1P modulators represent a novel and promising therapeutic strategy for immune-mediated diseases.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research